https://www.ncbi.nlm.nih.gov/pubmed/26552008
Menachery VD1, Yount BL Jr1, Debbink K1,2, Agnihothram S3, Gralinski LE1, Plante JA1, Graham RL1, Scobey T1, Ge XY4, Donaldson EF1, Randell SH5,6, Lanzavecchia A7, Marasco WA8,9, Shi ZL4, Baric RS1,2.
Author information
- 1
- Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- 2
- Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- 3
- National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas, USA.
- 4
- Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
- 5
- Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- 6
- Cystic Fibrosis Center, Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- 7
- Institute for Research in Biomedicine, Bellinzona Institute of Microbiology, Zurich, Switzerland.
- 8
- Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
- 9
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.